JSW
BSX icon

Journey Strategic Wealth’s Boston Scientific BSX Stock Holding History

Journey Strategic Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$886K Buy
14,122
+6,718
+91% +$537K 0.02% 208
2025
Q4 		$706K Buy
7,404
+1,933
+35% +$190K 0.02% 235
2025
Q3 		$534K Sell
5,471
-998
-15% -$103K 0.02% 281
2025
Q2 		$695K Buy
6,469
+3,192
+97% +$323K 0.02% 225
2025
Q1 		$331K Buy
3,277
+326
+11% +$32.8K 0.01% 312
2024
Q4 		$264K Buy
2,951
+39
+1% +$3.43K 0.01% 375
2024
Q3 		$244K Buy
+2,912
New +$230K 0.01% 395

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Journey Strategic Wealth's BSX Position: Q1 2026 in Review

Journey Strategic Wealth increased its Boston Scientific (BSX) stake by 91% in Q1 2026, buying an estimated $537K and bringing the position to 14,122 shares worth $886K. The position accounts for 0.02% of the portfolio, ranked #208.

Journey Strategic Wealth first reported a position in BSX in Q3 2024 and has held it in 7 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Journey Strategic Wealth held 14,122 shares of Boston Scientific worth $886K as of Q1 2026.
  • Journey Strategic Wealth bought 6,718 Boston Scientific shares in Q1 2026, an estimated $537K.
  • Boston Scientific made up 0.02% of Journey Strategic Wealth's portfolio in Q1 2026, its #208 holding.
  • Journey Strategic Wealth first reported a position in Boston Scientific in Q3 2024 and has held it in 7 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.